{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:24:17Z","timestamp":1784816657750,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10517-026-06622-z","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:23:20Z","timestamp":1775654600000},"page":"288-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Empagliflozin Alleviates Changes in Renal Expression of E- and N-Cadherins in Mice with Type 2 Diabetes Mellitus"],"prefix":"10.1007","volume":"180","author":[{"given":"A. I.","family":"Korbut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Ananishnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. P.","family":"Bgatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Muraleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. V.","family":"Klimontov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"1","key":"6622_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12882-025-04309-7","volume":"26","author":"Z Li","year":"2025","unstructured":"Li Z, He R, Wang Y, et al. Global trends of chronic kidney disease from 1990 to 2021: A systematic analysis for the global burden of disease study 2021. BMC Nephrol. 2025;26(1):385. https:\/\/doi.org\/10.1186\/s12882-025-04309-7","journal-title":"BMC Nephrol."},{"key":"6622_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115025","volume":"165","author":"W Guo","year":"2023","unstructured":"Guo W, Li H, Li Y, et al. Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors. Biomed Pharmacother. 2023;(165):115025. https:\/\/doi.org\/10.1016\/j.biopha.2023.115025","journal-title":"Biomed Pharmacother."},{"issue":"7","key":"6622_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/biomedicines11071995","volume":"11","author":"Q Hu","year":"2023","unstructured":"Hu Q, Saleem K, Pandey J, et al. Cell adhesion molecules in fibrotic diseases. Biomedicines. 2023;11(7):1995. https:\/\/doi.org\/10.3390\/biomedicines11071995","journal-title":"Biomedicines."},{"issue":"63","key":"6622_CR4","doi-asserted-by":"publisher","first-page":"106190","DOI":"10.18632\/oncotarget.22311","volume":"8","author":"DY Kim","year":"2017","unstructured":"Kim DY, Kang MK, Park SH, et al. Eucalyptol ameliorates Snail1\/\u03b2-catenin-dependent diabetic disjunction of renal tubular epithelial cells and tubulointerstitial fibrosis. Oncotarget. 2017;8(63):106190-205. https:\/\/doi.org\/10.18632\/oncotarget.22311","journal-title":"Oncotarget."},{"key":"6622_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/TCRM.S398163","volume":"19","author":"GB Colbert","year":"2023","unstructured":"Colbert GB, Madariaga HM, Gaddy A, et al. Empagliflozin in adults with chronic kidney disease (CKD): current evidence and place in therapy. Ther Clin Risk Manag. 2023;(19):133-42. https:\/\/doi.org\/10.2147\/TCRM.S398163","journal-title":"Ther Clin Risk Manag."},{"key":"6622_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109506","volume":"68","author":"NA Das","year":"2020","unstructured":"Das NA, Carpenter AJ, Belenchia A, et al. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition. Cell Signal. 2020;(68):109506. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109506","journal-title":"Cell Signal."},{"issue":"1","key":"6622_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00018-025-05688-8","volume":"82","author":"X Cai","year":"2025","unstructured":"Cai X, Cao H, Wang M, et al. SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2. Cell Mol Life Sci. 2025;82(1):159. https:\/\/doi.org\/10.1007\/s00018-025-05688-8","journal-title":"Cell Mol Life Sci."},{"issue":"3","key":"6622_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10517-019-04519-8","volume":"167","author":"AI Korbut","year":"2019","unstructured":"Korbut AI, Klimontov VV, Orlov NB, et al. Relationships between body composition and plasma levels of pancreatic, gut, and adipose tissue hormones in db\/db mice, a model of type 2 diabetes mellitus. Bull Exp Biol Med. 2019;167(3):325-8. https:\/\/doi.org\/10.1007\/s10517-019-04519-8","journal-title":"Bull Exp Biol Med."},{"key":"6622_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108503","volume":"249","author":"A Ashfaq","year":"2023","unstructured":"Ashfaq A, Meineck M, Pautz A, et al. A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy. Pharmacol Ther. 2023;(249):108503. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108503","journal-title":"Pharmacol Ther."},{"key":"6622_CR10","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;(347):1260419. https:\/\/doi.org\/10.1126\/science.1260419","DOI":"10.1126\/science.1260419"},{"issue":"5","key":"6622_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2337\/db23-0581","volume":"73","author":"A Nakatsuka","year":"2024","unstructured":"Nakatsuka A, Yamaguchi S, Wada J. GRP78 contributes to the beneficial effects of SGLT2 inhibitor on proximal tubular cells in DKD. Diabetes. 2024;73(5):763-79. https:\/\/doi.org\/10.2337\/db23-0581","journal-title":"Diabetes."},{"issue":"6","key":"6622_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/cells9061380","volume":"9","author":"SP Srivastava","year":"2020","unstructured":"Srivastava SP, Goodwin JE. Cancer biology and prevention in diabetes. Cells. 2020;9(6):1380. https:\/\/doi.org\/10.3390\/cells9061380","journal-title":"Cells."},{"issue":"3","key":"6622_CR13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/molecules28031112","volume":"28","author":"A Pawlos","year":"2023","unstructured":"Pawlos A, Broncel M, Wo\u017aniak E, et al. SGLT2 inhibitors may restore endothelial barrier interrupted by 25-hydroxycholesterol. Molecules. 2023;28(3):1112. https:\/\/doi.org\/10.3390\/molecules28031112","journal-title":"Molecules."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06622-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06622-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:01:28Z","timestamp":1776171688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06622-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6622"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06622-z","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}